June 21, 2021 – FDA Approves First Oral Blood Thinning Medication for Children
“June 21, 2021 Today, the U.S. Food and Drug Administration approved Pradaxa (dabigatran etexilate) oral pellets to treat children 3 months to less than 12 years old with venous thromboembolism (a condition where blood clots form in the veins) directly …